Literature DB >> 6194478

In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid.

M A Moskowitz, M Brody, L Y Liu-Chen.   

Abstract

The release of substance P-like immunoreactivity was examined using bovine pia arachnoid and its attendant blood vessels in vitro. At concentrations of 20,51, and 100 mM, potassium ions evoked the release of substance P-like immunoreactivity in a dose-dependent manner. The drug capsaicin released substance P at concentrations greater than 10(-8) M. Both potassium- and capsaicin-induced release were abolished by omitting calcium ions from the superfusion buffer. When subjected to separation by reverse phase high performance liquid chromatography, the superfusate from capsaicin perfused tissues contained a peak of immunoreactivity which migrated at the retention time corresponding to substance P. During basal and stimulated states, the percent endogenous substance P released ranged between 0.4-6.5 X 10(-2) and 1.3-11.6 X 10(-2) per minute, rates comparable to those previously reported by others using slices of dorsal horn or spinal cord segments. The immunoreactivity measurable in the conditioned buffer probably reflected release from afferent nerve endings in as much as most of the substance P immunoreactivity in pia arachnoid arises from trigeminal ganglia. Release of substance P, a cerebrovasodilating peptide from perivascular nerve endings in pia arachnoid suggests a possible role for substance P in the pathophysiology of disorders associated with pain of cerebrovascular origin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194478     DOI: 10.1016/0306-4522(83)90269-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

Review 1.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Effects of capsaicin on vascular smooth muscle.

Authors:  S P Duckles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

3.  Cerebrovascular responses to capsaicin in vitro and in situ.

Authors:  L Edvinsson; I Jansen; T A Kingman; J McCulloch
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity.

Authors:  K Messlinger; U Hanesch; M Baumgärtel; B Trost; R F Schmidt
Journal:  Anat Embryol (Berl)       Date:  1993-09

5.  Influence of perivascular peptides on endoneurial blood flow and microvascular resistance in the sciatic nerve of the rat.

Authors:  D W Zochodne; L T Ho
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

6.  Coiled mechanoreceptors in Aplysia revealed by sensorin immunofluorescence and confocal microscopy.

Authors:  I Steffensen; C E Morris
Journal:  Invert Neurosci       Date:  1996-09

Review 7.  Perivascular innervation of the cerebral circulation: involvement in the pathophysiology of subarachnoid hemorrhage.

Authors:  H Hara; L Edvinsson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

8.  A quantitative study of the central projection patterns of unmyelinated ventral root afferents in the cat.

Authors:  H J Häbler; W Jänig; M Koltzenburg; S B McMahon
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

9.  The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.

Authors:  J L Wilson; V Nayanar; J S Walker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  The vasodilator component of neurogenic inflammation is caused by a special subclass of heat-sensitive nociceptors in the skin of the pig.

Authors:  B Lynn; S Schütterle; F K Pierau
Journal:  J Physiol       Date:  1996-07-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.